Vanguard Global Advisers’s Evolus EOLS Stock Holding History

Vanguard Global Advisers’s Portfolio EOLS Stock Details EOLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$187K	Hold	26,926	–	–	﹤0.01%	2523
2026 Q1	$111K	Buy	+26,926	New	+$130K	﹤0.01%	2684

Other funds holding EOLS

NCM

Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $214M AUM 88.6% 1-Year Est. Return

Vanguard Global Advisers's EOLS Position: Q2 2026 in Review

Vanguard Global Advisers held its Evolus (EOLS) position steady in Q2 2026 at 26,926 shares worth $187K. The position accounts for ﹤0.01% of the portfolio, ranked #2523.

Vanguard Global Advisers first reported a position in EOLS in Q1 2026 and has held it in 2 quarters since. 157 funds tracked by Wall St. Rank hold EOLS as of Q2 2026.

Vanguard Global Advisers held 26,926 shares of Evolus worth $187K as of Q2 2026.
Vanguard Global Advisers left its Evolus share count unchanged in Q2 2026.
Evolus made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q2 2026, its #2523 holding.
Vanguard Global Advisers first reported a position in Evolus in Q1 2026 and has held it in 2 quarters since.
157 funds tracked by Wall St. Rank held Evolus as of Q2 2026.

Based on Vanguard Global Advisers's 13F filing for Q2 2026, filed 13 Aug 2026.